2004D-0035 - Draft Guidance for Industry on the Preclinical and Clinical Evaluation of Agents Used in the Prevention or Treatment of Postmenopausal Osteoporosis; Availability
FDA Comment Number : EC4
Submitter : Dr. Gary Galletta Date & Time: 04/13/2004 12:04:47
Organization : Procter and Gamble Pharmaceuticals
Drug Industry
Category :
Issue Areas/Comments
Please see the 8 page PDF document attached with comments on the 1994 Draft Osteoporosis Guidance.